title: Pregnancy results following embryo transfer in women receiving low-dosage variable-length estrogen replacement therapy for premature ovarian failure.
abstract: This study was undertaken to evaluate the effectiveness of a new, constant low-dose, variable-length estrogen replacement therapy in preparing the endometrium of women suffering premature ovarian failure for embryo implantation. Five of 10 patients receiving the new regime became pregnant following a total of 14 embryo transfers. This study proves the efficacy of low-dosage variable-length estrogen replacement therapy for preparing the endometrium for embryo implantation in patients suffering premature ovarian failure. These studies confirm earlier observations that sequentially increasing doses of estrogen during the follicular phase are unnecessary for implantation and that the length of the follicular phase within certain undefined limits is not critical. A second important observation arising from this study concerns the relative effectiveness of the route of administration of progesterone. Five of seven patients became pregnant after receiving vaginal pessaries, compared to none of seven following intramuscular injections.
authors.affiliation: Monash University Department of Obstetrics and Gynaecology Monash Medical Centre, Clayton, Victoria, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Leeton
authors.forename: P
authors.initials: P
authors.lastname: Rogers
authors.forename: I
authors.initials: I
authors.lastname: Cameron
authors.forename: C
authors.initials: C
authors.lastname: Caro
authors.forename: D
authors.initials: D
authors.lastname: Healy
mesh_terms: D000328:Adult; D004624:Embryo Transfer; D004958:Estradiol / Q000494:pharmacology / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008594:Menopause, Premature / Q000187:drug effects*; D009865:Oocytes; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D011374:Progesterone; D004958:Estradiol